These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2474220)

  • 21. [Evaluation of efficiency of the drug treatment of patients with toxic goiter].
    Zelinskiĭ BA; Slobodnianik OA
    Vrach Delo; 1978 Apr; (4):115-8. PubMed ID: 78584
    [No Abstract]   [Full Text] [Related]  

  • 22. [Basis for prescribing bradykinin antagonists in neurodermatitis and data on the therapeutic effectiveness of parmidin in this dermatosis].
    Grebennikov VA
    Vestn Dermatol Venerol; 1982 Sep; (9):46-9. PubMed ID: 7180192
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of prodectin in pulmonary tuberculosis].
    Safarov RN; Makinskiĭ AI
    Vrach Delo; 1981 Nov; (11):83-4. PubMed ID: 7342450
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of changes in the kallikrein-kinin system of blood in hypertension].
    Zholob VM; Vygovskiĭ VP; Vinokur KIa
    Klin Med (Mosk); 1987 Jan; 65(1):69-73. PubMed ID: 3645129
    [No Abstract]   [Full Text] [Related]  

  • 25. [Activity of the kallikrein-kinin system of the blood in patients with steroid-dependent bronchial asthma].
    Daniliak IG; Kuzzetsov VA; Tursunov KhKh
    Klin Med (Mosk); 1989 Dec; 67(12):48-50. PubMed ID: 2628617
    [No Abstract]   [Full Text] [Related]  

  • 26. [The kallikrein-kinin, coagulation and fibrinolytic systems of the blood in patients with chronic glomerulonephritis and the hypertension syndrome].
    Nazar PS; Cherniavskaia GF
    Vrach Delo; 1989 Aug; (8):6-8. PubMed ID: 2588532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [State of the kallikrein-kinin system in thyrotoxicosis].
    Perederiĭ VG; Kravchenko NI; Filipova DV
    Vrach Delo; 1980 Feb; (2):85-7. PubMed ID: 6899951
    [No Abstract]   [Full Text] [Related]  

  • 28. [State of the human kallikrein-kinin system indices during artificial ventilation with a helium-oxygen mixture under geneal anesthesia].
    Pokrovskiĭ GA; Kostylev EG; Ilysheva GN; Karpova LE
    Anesteziol Reanimatol; 1980; (3):33-4. PubMed ID: 6902629
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of the blood kallikrein-kinin system in the pathogenesis of functional cardiomyopathy in chronic tonsillitis patients].
    Vygovskiĭ VP; Dutka RIa
    Vrach Delo; 1987 Mar; (3):36-7. PubMed ID: 3647699
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical and experimental study of the effect of obsidan and hemiton on the blood kallikrein-kinin system].
    Akhmetova BKh; Didenko RG; Abdullina RN; Davidenko IuD
    Kardiologiia; 1982; 22(7):68-72. PubMed ID: 6921426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the state of microcirculation, rheologic properties of the blood and kallikrein-kinin system of patients with rheumatoid arthritis with systemic manifestations].
    Dormidontov EN; Frizen BN; Semin VA; Kalinnikova IN; Danilova TG
    Revmatologiia (Mosk); 1985; (4):10-3. PubMed ID: 3912886
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G; Gótzy G; Fehrentheil L
    Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current approaches to the treatment of diffuse toxic goiter].
    Balabolkin MI
    Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dynamics of the kallikrein-kinin system in patients with recurrent rheumatic carditis associated with heart defects after administration of inhibitors of the kallikrein-kinin system in complex antirheumatic therapy].
    Mikunis RI; Salobaĭ VA
    Ter Arkh; 1986; 58(7):89-91. PubMed ID: 2429381
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of lithium carbonate in treating patients with diffuse toxic goiter].
    Balabolkin MI; Petunina NA; Tsaguriia KG
    Klin Med (Mosk); 1990 Oct; 68(10):68-9. PubMed ID: 1706446
    [No Abstract]   [Full Text] [Related]  

  • 36. [Status of the blood kallikrein-kinin system in diabetes mellitus].
    Bezverkhaia TP; Sakhno TA
    Vrach Delo; 1982 Sep; (9):31-3. PubMed ID: 6924809
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of succinate-containing preparations in combine therapy of diffuse toxic goiter].
    Iakubovskii SV; Kondratenko GG; Popova II
    Klin Med (Mosk); 2014; 92(8):50-3. PubMed ID: 25790698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kallikrein-kinin system of blood in patients with acute pancreatitis].
    Orlov VA; Beliakov NV
    Sov Med; 1975 Nov; (11):24-8. PubMed ID: 1221522
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience using lithium carbonate in the complex treatment of diffuse toxic goiter].
    Petrov NM
    Ter Arkh; 1985; 57(12):32-6. PubMed ID: 3937256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood kallikrein-kinin system in patients with diabetes mellitus].
    Vygovskiĭ VP; Zaremba EF
    Vrach Delo; 1979 Apr; (4):42-4. PubMed ID: 452563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.